KENALOG-40 40 mg/mL

Triamcinolone acetonide, the active ingredient in Kenalog-40, is a corticosteroid presented as a 40 mg/mL injection, suspension for intra-articular or intramuscular use. It is used to treat inflammatory conditions such as osteoarthritis, rheumatoid arthritis, bursitis, tendinitis, and synovitis in adults and children over 1 month old. GNH USA supplies Kenalog-40 as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide.

Kenalog-40 is a synthetic glucocorticoid corticosteroid with anti-inflammatory and immunosuppressive properties. It is administered by healthcare professionals to relieve pain and inflammation in affected joints or muscles.

Kenalog-40 is used to treat various inflammatory conditions by reducing inflammation and suppressing the immune response. Common uses include:

- Osteoarthritis: Reduces pain and inflammation in the joints. - Rheumatoid arthritis: Helps manage joint inflammation and pain. - Bursitis: Alleviates inflammation in the bursae, the small fluid-filled sacs that cushion the bones, tendons, and muscles near the joints. - Tendinitis: Reduces inflammation in the tendons. - Synovitis: Helps manage inflammation of the synovial membrane, which lines joints.

Kenalog-40 may cause various side effects, ranging from mild to serious. Common Side Effects: - Increased appetite - Fluid retention - Mild, short-term increase in blood sugar - Increased risk of infection

Serious or Rare Side Effects: - Increased risk of infection - Joint damage - Changes in mood or personality - Osteoporosis - Eye problems, including cataracts and glaucoma - Adrenal insufficiency (low adrenal gland function) - Cushing syndrome - Low blood potassium level - Low blood calcium level - High blood pressure - Increased blood sugar, which can lead to type 2 diabetes

Kenalog-40 should be used with caution and under the supervision of a healthcare professional. Important precautions include: - Avoid use in neonates: This drug should not be used in neonates. - Allergic reactions: Seek immediate medical attention if signs of an allergic reaction occur. - Adrenal insufficiency: Monitor for symptoms of adrenal gland that is less active than normal. - Eye problems: Regular eye examinations are recommended to monitor for cataracts and glaucoma. - Bone density: Regular monitoring for changes in bone density is advised. - Store below 25°C: Keep in the original pack, protect from moisture.

Kenalog-40 may interact with other medications, potentially affecting its efficacy or increasing the risk of side effects. Major Interactions (Avoid): - Live vaccines: Avoid concurrent use with live vaccines due to the risk of infection. - Nonsteroidal anti-inflammatory drugs (NSAIDs): Increased risk of gastrointestinal side effects.

Moderate Interactions (Monitor Closely): - Anticoagulants: Monitor for changes in blood clotting. - Antidiabetic drugs: Monitor blood sugar levels closely. - Antihypertensives: Monitor blood pressure regularly.